DLA Piper advises Starpharma on majority ownership of Petalion Therapeutics

Advising firms

The announcement does not name an advising firm.

The announcement does not name individual lawyers.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value

Not stated

What the figure measures

Not stated

Client

Starpharma

Counterparties

Petalion Therapeutics (Target)
Medicxi (Other)